| Irwin, Michael R |
| Completed | 2 | 20 | US | Placebo, Saline (0.9%), Endotoxin, Escherichia coli | University of California, Los Angeles | Alcohol Use Disorder, Inflammatory Response, Craving, Depressed Mood | 11/23 | 11/23 | | |
NCT03848715: Sleep and Healthy Aging Research on Depression for Younger Women |
|
|
| Completed | 1 | 40 | US | Endotoxin, Placebo | University of California, Los Angeles | Anhedonia, Depression | 07/22 | 07/24 | | |
| Completed | 1 | 160 | US | Endotoxin, Placebo | Michael Irwin, MD | Depression in Old Age | 04/24 | 04/24 | | |
| Recruiting | 1 | 40 | US | Endotoxin, Placebo | University of California, Los Angeles, National Institute on Aging (NIA) | Anhedonia, Inflammation, Anxiety, Aging, Depression | 03/26 | 03/26 | | |
NCT04601961: Effects of TIVA Versus Inhalational Anaesthesia on Circulating Tumour Cells in Hepatocellular Carcinoma Patients |
|
|
| Recruiting | N/A | 220 | RoW | Propofol, Sevoflurane | The University of Hong Kong | Circulating Tumor Cell, Hepatocellular Carcinoma | 01/24 | 03/24 | | |
| Completed | N/A | 113 | US | Body Mind Training (BMT), Body Training (BT):, Usual Care (UC) | Rutgers, The State University of New Jersey, University of California, Los Angeles, University of New Mexico | Prostate Cancer, Bladder Cancer, Kidney Cancer, Colon Cancer, Rectum Cancer, Thyroid Cancer, Lung Cancer, Small Intestine Cancer, Soft Tissue Cancer | 03/23 | 03/23 | | |
NCT00690196: Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune Mechanisms |
|
|
| Active, not recruiting | N/A | 90 | US | Tai Chi Chih, TCC, Cognitive Behavioral Therapy, CBT | Jonsson Comprehensive Cancer Center, National Center for Research Resources (NCRR) | Sleep Disorders, Sleep Initiation and Maintenance Disorders, Dyssomnias, Mental Disorders, Nervous System Diseases | 07/25 | 07/26 | | |
| Not yet recruiting | N/A | 420 | US | Treatment As Usual, Active Condition, Active Comparator | University of Pittsburgh, Emory University, University of California, Berkeley, University of California, Los Angeles, Augusta University, National Institutes of Health (NIH), National Institute of Mental Health (NIMH) | Depression, Suicidality, Sleep | 08/29 | 08/30 | | |
| Miotto, Karen |
| Completed | 2 | 20 | US | Placebo, Saline (0.9%), Endotoxin, Escherichia coli | University of California, Los Angeles | Alcohol Use Disorder, Inflammatory Response, Craving, Depressed Mood | 11/23 | 11/23 | | |
| Shoptaw, Steven |
NCT04614584: Mirtazapine and Methamphetamine Drug-drug Interaction Study |
|
|
| Completed | 1 | 15 | US | Mirtazapine, Methamphetamine | San Francisco Department of Public Health, University of California, Los Angeles | Methamphetamine Use Disorder, Drug Interaction, Cardiovascular Abnormalities | 05/24 | 05/24 | | |
| Enrolling by invitation | N/A | 200 | US | Opioid Addiction Recovery Support Software Platform, OARS | Q2i, LLC, University of California, Los Angeles, National Institute on Drug Abuse (NIDA) | Opioid-use Disorder | 05/23 | 08/23 | | |
NCT04801758: Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 704/HPTN 085 AMP Study |
|
|
| Completed | N/A | 18 | RoW | Analytical Treatment Interruption | HIV Vaccine Trials Network, National Institute of Allergy and Infectious Diseases (NIAID), HIV Prevention Trials Network, Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | HIV Infection | 07/24 | 07/24 | | |
| Li, Gang |
HEARTRIP, NCT03809273: Effects of Yangxinshi Pills on the Exercise Tolerance Compared With Trimetazidine in Patients After PCI |
|
|
| Recruiting | 4 | 668 | RoW | Yangxinshi, Trimetazidine, Yangxinshi mimic, Trimetazidine mimic | Shenyang Northern Hospital | Percutaneous Coronary Intervention | 12/20 | 12/20 | | |
| Active, not recruiting | 4 | 948 | Europe, Canada, US, RoW | Edoxaban, Lixiana, Savaysa, Non-anticoagulant medical therapy | Population Health Research Institute | Intracranial Hemorrhages, Atrial Fibrillation | 04/26 | 10/26 | | |
NCT05182463: Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients |
|
|
| Recruiting | 4 | 5000 | RoW | Peginterferon Alfa-2B, Nucleoside Analogs | Third Affiliated Hospital, Sun Yat-Sen University | Hepatitis B, Chronic | 12/26 | 11/29 | | |
| Completed | 3 | 2425 | RoW | urapidil, Intensive BP lowing | The George Institute for Global Health, China, Shanghai East Hospital, China, First Affiliated Hospital of Chengdu Medical College, China, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, China | Stroke, Acute, Cerebrovascular Disorders | 11/23 | 11/23 | | |
EAST, NCT06773364: Early Initiated Ambulance-delivered Levetiracetam and Headposition in Hyper-acute Stroke Trial |
|
|
| Not yet recruiting | 3 | 2423 | NA | Levetiracetam, Guide-recommended management, The lying flat (0°) head position, The sitting-up (≥30°) head position | Shanghai East Hospital | Suspected Stroke | 12/28 | 12/29 | | |
ATEM, NCT05416476: Anisodine Hydrobromide For The Preventive Treatment Of Episodic Migraine |
|
|
| Recruiting | 3 | 288 | RoW | Anisodine Hydrobromide, Anisodine Hydrobromide placebo | Second Affiliated Hospital, School of Medicine, Zhejiang University | Migraine Without Aura, Migraine With Aura | 10/25 | 12/25 | | |
| Recruiting | 3 | 1500 | Europe, RoW | Donanemab, (LY3002813), Placebo | Eli Lilly and Company | Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Tauopathies, Neurodegenerative Diseases, Neurocognitive Disorders, Mental Disorders | 04/27 | 04/27 | | |
| Completed | 2 | 200 | RoW | Intravenous tirofiban combination therapy, Tirofiban | Shanghai East Hospital, Shanghai 6th People's Hospital, Ningbo No. 1 Hospital, Zhangzhou Municipal Hospital of Fujian Province, Shanghai 7th People's Hospital, Jinan Central Hospital, Xuchang Central Hospital | Ischemic Stroke | 07/23 | 10/23 | | |
PANDORA, NCT04995016: Pembrolizumab and Axitinib as Neoadjuvant Therapy for Locally Advanced Non-metastatic Clear Cell Renal Cell Carcinoma |
|
|
| Not yet recruiting | 2 | 18 | RoW | Pembrolizumab, Keytruda, Axitinib, Inlyta | Tianjin Medical University Second Hospital | Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma | 08/22 | 08/23 | | |
| Recruiting | 1/2 | 380 | RoW | PM8002 | Biotheus Inc. | Malignant Neoplasm | 11/25 | 11/25 | | |
NCT04093336: Effect of Mesenchymal Stem Cells(MSCs) Transplantation for Acute Cerebral Infarction Patients |
|
|
| Recruiting | 1/2 | 120 | RoW | human umbilical cord mesenchymal stem cells, Placebo, standardized treatment | Shanghai East Hospital | Infarction, Middle Cerebral Artery, Infarction, Anterior Cerebral Artery, Cerebral Infarction, Stroke, Ischemic, Acute Stroke, Brain Infarction, Infarction, PCA, Infarction, Posterior Circulation, Brain | 12/24 | 12/24 | | |
NCT04137926: A Multicenter Study on the Diagnosis and Intervention of New Biomarkers on the Prodromal Stage of Alzheimer's Disease |
|
|
| Recruiting | N/A | 360 | RoW | MicRNAs battery | Shanghai Mental Health Center | Alzheimer's Disease | 08/22 | 11/22 | | |
NCT06468436: Dexmedetomidine-Esketamine Combination for Sedation and Analgesia in ICU Patients |
|
|
| Not yet recruiting | N/A | 1508 | RoW | Dexmedetomidine-Esketamine Combination, Dexmedetomidine hydrochloride, Esketamine hydrochloride, Dexmedetomidine | Peking University First Hospital, Peking University International Hospital, Tianjin Medical University General Hospital | Aged, Intensive Care Units, Ventilators, Mechanical, Dexmedetomidine, Esketamine, Delirium | 06/30 | 12/30 | | |
NCT05755776: The Efficacy and Safety of Tenofovir Amibufenamide to Treat Low-level Viraemia After Entecavir Treatment |
|
|
| Recruiting | N/A | 204 | RoW | TMF, Heng Mu | The Second Affiliated Hospital of Chongqing Medical University, Jiangsu Hansoh Pharmaceutical Co., Ltd. | Chronic Hepatitis B | 12/24 | 12/24 | | |
NCT04995159: Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVasâ„¢ BRS System |
|
|
| Not yet recruiting | N/A | 2150 | RoW | Single anti-platelet therapy, SAPT strategy, Dual anti-platelet therapy, DAPT strategy | Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Heart Disease | 01/26 | 01/28 | | |
| Ray, Lara |
NCT03594435: Ibudilast for the Treatment of Alcohol Use Disorder |
|
|
| Completed | 2 | 102 | US | Ibudilast, Pinatos, MN-166, Placebo oral capsule, Sugar Pill | University of California, Los Angeles, National Institute on Alcohol Abuse and Alcoholism (NIAAA), MediciNova | Alcohol Use Disorder | 04/23 | 04/23 | | |
NCT03878316: Intranasal Oxytocin for the Treatment of Alcohol Use Disorder |
|
|
| Completed | 2 | 100 | US | Instranasal Oxytocin | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Alcohol Use Disorder, Alcohol Misuse | 10/23 | 10/23 | | |
NCT06494891: Motivation for IV Alcohol Self-Administration in Humans |
|
|
| Recruiting | 2 | 210 | US | Intravenous Alcohol | University of California, Los Angeles | Alcohol Use Disorder | 04/27 | 06/27 | | |
| Completed | 2 | 20 | US | Placebo, Saline (0.9%), Endotoxin, Escherichia coli | University of California, Los Angeles | Alcohol Use Disorder, Inflammatory Response, Craving, Depressed Mood | 11/23 | 11/23 | | |
| Not yet recruiting | 2 | 76 | US | Suvorexant, SUV, Dual orexin receptor antagonist, Placebo | Pharmacotherapies for Alcohol and Substance Use Disorders Alliance, University of California, Los Angeles, The University of Texas Health Science Center, Houston | Alcohol Use Disorder (AUD), Post Traumatic Stress Disorder (PTSD), Insomnia | 06/26 | 06/26 | | |
AFA-281-304, NCT06710431: A Study of the Safety and Exploratory Efficacy of Oral AFA-281 in Patients with Alcohol Use Disorder |
|
|
| Not yet recruiting | 2 | 36 | US | AFA-281 | Afasci Inc | Alcohol Abuse, Alcohol Abuse/addiction, Anxiety, Pain Threshold, Depression Disorders, Sleep Disorder | 06/27 | 12/27 | | |
| Jenkins, Jessica |
NCT03878316: Intranasal Oxytocin for the Treatment of Alcohol Use Disorder |
|
|
| Completed | 2 | 100 | US | Instranasal Oxytocin | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Alcohol Use Disorder, Alcohol Misuse | 10/23 | 10/23 | | |
NCT06494891: Motivation for IV Alcohol Self-Administration in Humans |
|
|
| Recruiting | 2 | 210 | US | Intravenous Alcohol | University of California, Los Angeles | Alcohol Use Disorder | 04/27 | 06/27 | | |
| Completed | 2 | 20 | US | Placebo, Saline (0.9%), Endotoxin, Escherichia coli | University of California, Los Angeles | Alcohol Use Disorder, Inflammatory Response, Craving, Depressed Mood | 11/23 | 11/23 | | |
| Not yet recruiting | 2 | 76 | US | Suvorexant, SUV, Dual orexin receptor antagonist, Placebo | Pharmacotherapies for Alcohol and Substance Use Disorders Alliance, University of California, Los Angeles, The University of Texas Health Science Center, Houston | Alcohol Use Disorder (AUD), Post Traumatic Stress Disorder (PTSD), Insomnia | 06/26 | 06/26 | | |
NCT04248283: Adjustable Continence Therapy (ACT) for the Treatment of Female SUI |
|
|
| Recruiting | N/A | 167 | US | Adjustable Continence Therapy for Women (ACT) | Uromedica | Urinary Incontinence, Urinary Incontinence,Stress | 09/25 | 12/25 | | |
| Recruiting | N/A | 240 | US | Cystoscopy, Bladder EpiCheck urine test, Xpert Bladder Cancer Monitor urine test | White River Junction Veterans Affairs Medical Center, National Cancer Institute (NCI), University of Texas Southwestern Medical Center, Medical University of South Carolina | Non-muscle-invasive Bladder Cancer | 11/28 | 12/28 | | |
| Levanthal, Adam |
| No trials found |
| Lunny, Katy |
| No trials found |
